161 related articles for article (PubMed ID: 36917189)
1. New insights into breast microcalcification for poor prognosis: NACT cohort and bone metastasis evaluation cohort.
Hu Y; Mao L; Wang M; Li Z; Li M; Wang C; Ji L; Zeng H; Zhang X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7285-7297. PubMed ID: 36917189
[TBL] [Abstract][Full Text] [Related]
2. Human Epidermal Growth Factor 2-positive Breast Cancer with Mammographic Microcalcification: Relationship to Pathologic Complete Response after Neoadjuvant Chemotherapy.
Mazari FAK; Sharma N; Dodwell D; Horgan K
Radiology; 2018 Aug; 288(2):366-374. PubMed ID: 29786482
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients.
Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
Cancer Causes Control; 2021 Mar; 32(3):251-260. PubMed ID: 33377172
[TBL] [Abstract][Full Text] [Related]
4. MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?
Sella T; Simor B; Adler-Levy Y; Maly B; Kadouri L; Carmon E
Eur Radiol; 2023 Oct; 33(10):7168-7177. PubMed ID: 37086288
[TBL] [Abstract][Full Text] [Related]
5. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
[TBL] [Abstract][Full Text] [Related]
6. Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?
Savaridas SL; Sim YT; Vinnicombe SJ; Purdie CA; Thompson AM; Evans A
Cancer Imaging; 2019 Oct; 19(1):67. PubMed ID: 31639053
[TBL] [Abstract][Full Text] [Related]
7. Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI.
Savaridas SL; Vinnicombe SJ; Warwick V; Evans A
Br J Radiol; 2023 Aug; 96(1148):20220921. PubMed ID: 37399083
[TBL] [Abstract][Full Text] [Related]
8. The association between body mass index and pathological complete response in neoadjuvant-treated breast cancer patients.
Skarping I; Blaabjerg Pedersen S; Förnvik D; Zackrisson S; Borgquist S
Acta Oncol; 2022 Jun; 61(6):731-737. PubMed ID: 35363106
[TBL] [Abstract][Full Text] [Related]
9. The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy.
Cullinane C; Brien AO; Shrestha A; Hanlon EO; Walshe J; Geraghty J; Evoy D; McCartan D; McDermott E; Prichard R
Breast Cancer Res Treat; 2022 Jul; 194(2):385-392. PubMed ID: 35606616
[TBL] [Abstract][Full Text] [Related]
10. The accuracy of MRI in detecting pathological complete response following neoadjuvant chemotherapy in different breast cancer subtypes.
Kuzmova M; Cullinane C; Rutherford C; McCartan D; Rothwell J; Evoy D; Geraghty J; Prichard RS
Surg Oncol; 2023 Dec; 51():102011. PubMed ID: 37931546
[TBL] [Abstract][Full Text] [Related]
11. Mammographic microcalcifications and risk of breast cancer.
Azam S; Eriksson M; Sjölander A; Gabrielson M; Hellgren R; Czene K; Hall P
Br J Cancer; 2021 Aug; 125(5):759-765. PubMed ID: 34127810
[TBL] [Abstract][Full Text] [Related]
12. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
13. [Pathological and mammographic findings of microcalcification in calcified breast carcinoma without a mass].
Chen W; Qin G; Xu W; Liao X; Wen C; Zhang L; Ouyang C
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):523-7. PubMed ID: 24752101
[TBL] [Abstract][Full Text] [Related]
14. Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer.
Hall C; Krishnamurthy S; Lodhi A; Bhattacharyya A; Anderson A; Kuerer H; Bedrosian I; Singh B; Lucci A
Cancer; 2012 Jan; 118(2):342-8. PubMed ID: 21717428
[TBL] [Abstract][Full Text] [Related]
15. HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC.
Li JJ; Yu Y; Ge J
Breast Cancer; 2023 May; 30(3):364-378. PubMed ID: 36656510
[TBL] [Abstract][Full Text] [Related]
16. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
Skarping I; Förnvik D; Zackrisson S; Borgquist S; Rydén L
Breast Cancer Res Treat; 2021 Aug; 189(1):131-144. PubMed ID: 34120224
[TBL] [Abstract][Full Text] [Related]
17. Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors.
Salim DK; Mutlu H; Eryilmaz MK; Musri FY; Tural D; Gunduz S; Coskun HS
Asian Pac J Cancer Prev; 2014; 15(21):9379-83. PubMed ID: 25422228
[TBL] [Abstract][Full Text] [Related]
18. Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma.
Castaneda CA; Flores R; Rojas K; Flores C; Castillo M; Milla E
Hematol Oncol Stem Cell Ther; 2014 Dec; 7(4):149-56. PubMed ID: 25300565
[TBL] [Abstract][Full Text] [Related]
19. Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden.
Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
Breast; 2020 Oct; 53():33-41. PubMed ID: 32563178
[TBL] [Abstract][Full Text] [Related]
20. Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study.
Woo J; Oh SJ; Song JY; Chae BJ; Choi JE; Lee J; Park HK; ; Lim W
BMC Cancer; 2021 May; 21(1):647. PubMed ID: 34059020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
